The use of muscle relaxants in the intensive care unit.
Booij
L H
LH
Institute for Anesthesiology, University of Nijmegen, The Netherlands.
D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003422:Critical Care; D004347:Drug Interactions; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D018482:Muscle, Skeletal / Q000187:drug effects; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects; D009468:Neuromuscular Diseases / Q000139:chemically induced; D012119:Respiration / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D013618:Tachyphylaxis / Q000502:physiology
D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents